- smallcaps.com.au
- Posted On 12 November 2026
Clarity Pharmaceuticals Granted Breakthrough Therapy Designation for Prostate Cancer Copper Theranostic
The US Food and Drug Adminstration has granted Clarity Pharmaceuticals (ASX: CU6) breakthrough therapy designation for 64Cu-SAR-bisPSMA used in positron emissio...
Source:
smallcaps.com.au